310 related articles for article (PubMed ID: 10073946)
1. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.
Jong MC; Hofker MH; Havekes LM
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):472-84. PubMed ID: 10073946
[No Abstract] [Full Text] [Related]
2. Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
Jong MC; Havekes LM
Int J Tissue React; 2000; 22(2-3):59-66. PubMed ID: 10937355
[TBL] [Abstract][Full Text] [Related]
3. Quartet of APOCs and the Different Roles They Play in Diabetes.
Hsu CC; Kanter JE; Kothari V; Bornfeldt KE
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1124-1133. PubMed ID: 37226733
[TBL] [Abstract][Full Text] [Related]
4. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mouse models of lipoprotein metabolism and atherosclerosis.
Breslow JL
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8314-8. PubMed ID: 8378301
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
van der Hoogt CC; Berbée JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC
Biochim Biophys Acta; 2006 Feb; 1761(2):213-20. PubMed ID: 16478678
[TBL] [Abstract][Full Text] [Related]
7. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of apolipoprotein C: kinetic studies in human subjects: a critical review.
Malmendier CL; Lontie JF; Grutman G; Delcroix C
Adv Exp Med Biol; 1987; 210():95-103. PubMed ID: 3296684
[No Abstract] [Full Text] [Related]
9. Kinetics of heterogeneous populations of particles.
Malmendier GL; Lontie JF; Delcroix C; Dubois DY
Adv Exp Med Biol; 1991; 285():223-32. PubMed ID: 1858552
[No Abstract] [Full Text] [Related]
10. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.
Jong MC; Gijbels MJ; Dahlmans VE; Gorp PJ; Koopman SJ; Ponec M; Hofker MH; Havekes LM
J Clin Invest; 1998 Jan; 101(1):145-52. PubMed ID: 9421476
[TBL] [Abstract][Full Text] [Related]
11. Defects of lipoprotein metabolism in familial combined hyperlipidaemia.
de Graaf J; Stalenhoef AF
Curr Opin Lipidol; 1998 Jun; 9(3):189-96. PubMed ID: 9645500
[TBL] [Abstract][Full Text] [Related]
12. Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase.
Jackson RL; Tajima S; Yamamura T; Yokoyama S; Yamamoto A
Biochim Biophys Acta; 1986 Feb; 875(2):211-9. PubMed ID: 3942763
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of Apoe and Apoc1 by two consecutive rounds of gene targeting: effects on mRNA expression levels of gene cluster members.
van Ree JH; van den Broek WJ; van der Zee A; Dahlmans VE; Wieringa B; Frants RR; Havekes LM; Hofker MH
Hum Mol Genet; 1995 Aug; 4(8):1403-9. PubMed ID: 7581381
[TBL] [Abstract][Full Text] [Related]
14. Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI.
Lusis AJ; Heinzmann C; Sparkes RS; Scott J; Knott TJ; Geller R; Sparkes MC; Mohandas T
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3929-33. PubMed ID: 3459164
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of lipids and ApoC levels in Alzheimer's patients with and without cardiovascular disease.
Adunsky A; Chesnin V; Davidson M; Gerber Y; Alexander K; Haratz D
J Gerontol A Biol Sci Med Sci; 2002 Nov; 57(11):M757-61. PubMed ID: 12403806
[TBL] [Abstract][Full Text] [Related]
16. Increased response to cholesterol feeding in apolipoprotein C1-deficient mice.
van Ree JH; Hofker MH; van den Broek WJ; van Deursen JM; van der Boom H; Frants RR; Wieringa B; Havekes LM
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):905-11. PubMed ID: 7848292
[TBL] [Abstract][Full Text] [Related]
17. The roles of C-apolipoproteins in the metabolism of triglyceride-rich lipoproteins.
Reckless JP; Stocks J; Holdsworth G
Clin Sci (Lond); 1982 Feb; 62(2):125-9. PubMed ID: 7053911
[No Abstract] [Full Text] [Related]
18. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
[TBL] [Abstract][Full Text] [Related]
19. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
Jong MC; van Ree JH; Dahlmans VE; Frants RR; Hofker MH; Havekes LM
Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):445-50. PubMed ID: 9020879
[TBL] [Abstract][Full Text] [Related]
20. [Apolipoprotein C-I, C-II, C-III].
Fukushima N; Yamamoto K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():110-3. PubMed ID: 15658276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
